Loading...
Citius Oncology, Inc.
CTOR•NASDAQ
Healthcare
Drug Manufacturers - General
$4.35
$-0.15(-3.33%)
Citius Oncology, Inc. (CTOR) Company Profile & Overview
Explore Citius Oncology, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Citius Oncology, Inc. (CTOR) Company Profile & Overview
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.
SectorHealthcare
IndustryDrug Manufacturers - General
CEOLeonard L. Mazur
Contact Information
347-627-0058
420 Lexington Avenue, New York City, NY, 10170
Company Facts
CountryUS
Actively Trading